Profile
Samuel Henderson is currently the Chief Scientific Officer at Cerecin, Inc. Previously, he worked as a Principal at The University of Colorado and as a Lead Scientist at Genoplex, Inc. He completed his undergraduate degree at the University of Washington and obtained his doctorate from the University of Chicago.
Samuel Henderson active positions
| Companies | Position | Start |
|---|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Chief Tech/Sci/R&D Officer | - |
Former positions of Samuel Henderson
| Companies | Position | End |
|---|---|---|
Genoplex, Inc.
Genoplex, Inc. Packaged SoftwareTechnology Services Develops AI-powered technology platform to simplify the logistics of patient referrals for advanced therapies | Chief Tech/Sci/R&D Officer | - |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Samuel Henderson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genoplex, Inc.
Genoplex, Inc. Packaged SoftwareTechnology Services Develops AI-powered technology platform to simplify the logistics of patient referrals for advanced therapies | Technology Services |
- Stock Market
- Insiders
- Samuel Henderson
















